In addition, a recent study based on RNA-sequencing data proposed OXER1 as a key gene and possible molecular marker of tumorigenesis of Hormone-Receptor-positive/Human Epidermal Growth Factor Receptor 2 (also known as Receptor Tyrosine-Protein Kinase erbB-2, cluster of differentiation 340 (CD340), or proto-oncogene Neu)-negative (HR(+)/HER2(−)) breast cancer in adolescents and young adults [39]. This evidence concerns the gene OXER1 and breast carcinoma.